Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000080255-25-000800
Filing Date
2025-11-14
Accepted
2025-11-14 12:19:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5904
  Complete submission text file 0000080255-25-000800.txt   7908
Mailing Address P.O. BOX 89000 BALTIMORE MD 21289
Business Address 1307 POINT STREET BALTIMORE MD 21231 (410)345-2000
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) CIK: 0000080255 (see all company filings)

EIN.: 520556948 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
(CF Office: 09 Crypto Assets)

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 251483432
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)